| Literature DB >> 31064378 |
Frauke Luft1, Sarvi Sharifi2, Winfred Mugge3, Alfred C Schouten3, Lo J Bour2, Anne-Fleur van Rootselaar2, Peter H Veltink4, Tijtske Heida4.
Abstract
BACKGROUND: The basal ganglia and cerebellum are brain structures involved in movement initiation, execution and termination. They are thought to be involved in the tremor generation and movement deficits in Parkinson's disease (PD) and essential tremor (ET). Especially in PD, maintaining cyclic movement, such as walking or tapping can be significantly disturbed. Providing external cues improves timing of these movements in PD but its effect on ET has not yet been studied in depth. The aim of this study is to evaluate the usefulness of a bimanual tapping task as a tool during clinical decision making.Entities:
Keywords: Auditory cue; Essential tremor; Kinetic tremor; Parkinson’s disease; Tapping accuracy; Tapping variability
Mesh:
Year: 2019 PMID: 31064378 PMCID: PMC6505201 DOI: 10.1186/s12984-019-0528-6
Source DB: PubMed Journal: J Neuroeng Rehabil ISSN: 1743-0003 Impact factor: 4.262
Overview of included subjects
| Subject | Gender | Age | Duration (Years) | Medication |
|---|---|---|---|---|
| PD 1 | M | 69 | 5 | Levodopa, Trihexyphenidyl |
| PD 2 | M | 67 | 4 | Propranolol, Rasagilin |
| *PD 3 | F | 81 | 5 | Trihexyphenidyl |
| *PD 4 | M | 62 | 2 | Levodopa, Metoprolol succinat |
| PD 5 | M | 71 | 2 | Levodopa |
| PD 6 | F | 43 | 3 | – |
| PD 7 | M | 68 | 8 | Levodopa, Rasagilin, perindopril, omeprazole |
| PD 8 | M | 64 | 15 | – |
| PD 9 | M | 67 | 11 | Levodopa, Benserazid |
| *PD 10 | F | 56 | 9 | Levodopa, Carbidopa, Amandatin |
| PD 11 | M | 64 | 7 | – |
| ET 1 | M | 50 | 50 | – |
| ET 2 | F | 81 | 21 | – |
| * ET 3 | M | 54 | 4 | Propranolol |
| ET 4 | M | 85 | Childhood | Propranolol |
| * ET 5 | M | 65 | Childhood | – |
| ET 6 | F | 51 | Childhood | – |
| * ET 7 | M | 65 | 45 | Propranolol |
| ET 8 | F | 23 | Childhood | – |
| ET 9 | M | 49 | 9 | Propranolol |
| ET 10 | M | 54 | Childhood | – |
| ET 11 | M | 70 | Childhood | – |
| ET 12 | M | 64 | Childhood | – |
| ET 13 | M | 55 | Childhood | – |
| * ET 14 | M | 72 | 12 | Propranolol |
| ET 15 | M | 27 | Childhood | – |
| ET 16 | F | 81 | Childhood | – |
| ET 17 | M | 45 | Childhood | – |
PD = Parkinson’s Disease, ET = Essential Tremor, M = Male and F = Female, R = Right hand, L = Left hand. The asterisk * marks the subjects that were either excluded (Essential Tremor and Healthy Controls) due to technical failure or false execution of the task or not able to perform the 4 Hz tapping task (Parkinson’s disease)
Overview tremor frequencies
| Subject | Rest (Hz) (R/L) | Posture (Hz) (R/L) | Tapping (Hz) (R/L) |
|---|---|---|---|
| PD 1 | 5/5 | 6/5 | 6/6 |
| PD 2 | 5/5 | 7/8 | −/6 |
| *PD 3 | 6/4 | 5/7 | −/5 |
| *PD 4 | 6/6 | 7/7 | 7/7 |
| PD 5 | 9/8 | 6/6 | −/6 |
| PD 6 | 8/8 | 9/8 | −/− |
| PD 7 | 4/5 | 5/6 | 6/6 |
| PD 8 | 6/6 | 6/7 | −/− |
| PD 9 | 7/6 | 6/7 | 5/− |
| *PD 10 | 6/6 | 5/5 | −/− |
| PD 11 | 6/7 | 6/8 | −/− |
| ET 1 | 6/7 | 6/6 | −/− |
| ET 2 | 5/5 | 7/6 | 6/5 |
| * ET 3 | – | – | – |
| ET 4 | 8/6 | 5/6 | −/− |
| * ET 5 | – | – | – |
| ET 6 | 7/6 | 7/7 | 7/7 |
| * ET 7 | – | – | – |
| ET 8 | 8/7 | 7/8 | −/8 |
| ET 9 | 7/7 | 5/6 | 7/− |
| ET 10 | 6/6 | 6/7 | 6/6 |
| ET 11 | 5/9 | 7/7 | −/− |
| ET 12 | 7/4 | 7/7 | 9/− |
| ET 13 | 8/8 | 8/8 | 8/7 |
| * ET 14 | – | – | – |
| ET 15 | 6/6 | 5/7 | −/7 |
| ET 16 | 5/5 | 5/10 | 6/6 |
| ET 17 | 7/7 | 6/7 | −/− |
PD = Parkinson’s Disease, ET = Essential Tremor, R = Right hand, L = Left hand. The tremor frequencies are given for each individual patient. For the postural tremor patients had both arms outstretched in front of them at shoulder level
Fig. 1Example of the time signal and corresponding power spectral density. Time signal (10 s) and power spectral density (PSD) (of all epochs) of the EMG (top) and accelerometer (bottom) data. Time signals are presented in the left figure and the PSD in the right Fig. a) Data are of a representative healthy subject. b) Data are of an ET patient with high power kinetic tremor at 6 Hz. c) Data are of a PD patient with high power kinetic tremor at 4 Hz
Fig. 2Tapping accuracy. Tapping accuracy determined with the accelerometers for the 2 Hz (a) and 4 Hz (b) tapping task. Significant differences between individual task/hand combination are indicated by asterisks. HC = Healthy controls (light grey); ET = Essential Tremor (dark grey); PD = Parkinson’s Disease (black)
Fig. 3Tapping variability. Tapping variability determined with the accelerometers for the 4 Hz (a) and EMG data of the 4 Hz (b) tapping task. Inter-group differences between individual task/hand combination are indicated by two asterisks. HC = Healthy controls (light grey); ET = Essential Tremor (dark grey); PD = Parkinson’s Disease (black); R = Right hand; L = Left hand
Fig. 4Effect of kinetic tremor on the tapping frequency. Tapping frequency vs. kinetic tremor frequency, determined from EMG data, during the 2 Hz (a) and 4 Hz (b) tapping task. In black the results of the PD group are given and in grey the results of the ET group